Skip to content
DataLookout
Menu

BIOMINRISKNCT06244433

Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 9 words Show 5 more changesShow less
    • Trial completed
    • Final enrollment: 98 participants (planned 650)
    • Study completion date changed from estimate of Oct 27, 2027 to Oct 26, 2026
    • Site details revised at 18 of 18 sites
    • Publications: details revised at 1 of 1 entry
  2. Minor Trial sites expanded: 15 → 18 locationsv5
  3. Minor Primary completion date: Aug 2026 to Aug 27, 2026
    • Study completion date: Oct 2027 to Oct 27, 2027
    v4
  4. Minor Study sites: 1 to 15
    • Secondary endpoints expanded, about 16 words
    • Collaborators: 1 to 2
    v3
  5. Notable Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Start date changed from estimate of Feb 2024 to Aug 27, 2024
    • Primary completion date: Feb 2026 to Aug 2026
    • Study completion date: Apr 2027 to Oct 2027
    • Site details revised
  6. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Identification of genetic variants
Timeframe: up to 38 months

Secondary (2)

Identification of heterozygous variants or CNVs (copy number variants)
Identification of new genotype - phenotype correlations

Arms and interventions

SUDI cases

Sudden unexpected death in infant (SUDI) cases registered within the French National Registry of SUDI

Parents

Both parents of identified SUDI

Genetic: whole genome sequencing

Sites

18 sites in 1 country